Stay updated with breaking news from Us Trustee Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Supreme Court justices appeared divided over Purdue Pharma’s bankruptcy deal Monday, questioning whether it can immunize the Sackler family from civil lawsuits for their role in the opioid crisis. Described by experts as among the most important corporate bankruptcy cases in decades, the dispute will dictate the fate of the years-in-the-making settlement and more broadly…
(CNN) — The Supreme Court is hearing oral arguments Monday morning in one of the highest-profile bankruptcy cases in recent memory: Whether or not to approve<a class="excerpt-read-more" href="https://whdh.com/news/us-supreme-court-scrutinizes-controversial-opioid-crisis-settlement-that-would-give-sackler-family-immunity/">Read More</a>
A divided Supreme Court considered Monday whether the family that made its fortune on drugs fueling the nation's opioid epidemic could be shielded from civil litigation by agreeing to a $6 billion bankruptcy settlement for victims and recovery programs.
Supreme Court will decide if Sackler family is entitled to immunity from opioid lawsuits
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/cmg/G3FUVJJ66VDTNMFM4V3OE7JMPU.png)
The U.S. Supreme Court heard arguments Monday about a bankruptcy settlement that would pay billions of dollars to victims of the opioid crisis.